☰
Skip to content
Home
Studies
BioFINDER One
BioFINDER Two
BioFINDER Sleep
BioFINDER Preclinical AD
BioFINDER Primary Care
BioFINDER Memory Clinic
Study Group
Publications
News
För allmänheten
BrainWise
Delta i våra studier
Associations between the EAT-Lancet planetary health diet and incident dementia.
2025
J Prev Alzheimers Dis. 2025 Apr 12:100166. doi: 10.1016/j.tjpad.2025.100166. Online ahead of print. PMID: 40222839 Free article.
Samuelsson J, Glans I, Stubbendorff A, Ericson U, Palmqvist S, Hansson O, Sonestedt E.
J Prev Alzheimers Dis. 2025 Apr 12:100166. doi: 10.1016/j.tjpad.2025.100166. Online ahead of print.PMID: 40222839 Free article.
2026
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.
2026
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
2026
Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer’s disease.
2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease
2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer’s disease: A global perspective from the Global Alzheimer’s Leadership Series (GoALS).
2026
Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort.
2026
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
2026
Turning as a single and dual task-associations with Alzheimer’s and vascular pathologies in cognitively healthy older people.
2026
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.
2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females.
2026
Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts.
2026
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer’s disease
2026
Generating synthetic tau-PET scans in Alzheimer’s disease from MRI, blood biomarkers and demographics with deep learning.
2026
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire.
2026
Comparability of Centiloid values from [18F]flutemetamol scans using seven commercial and research software